Skip to main content

sepsis, vermoedelijk focus cholangitis

Advices

≥ 18 years
Priority Medication Remarks
Priority:
1st choice
Medication:

amoxicilline iv 1000mg 4dd

+

aminoglycoside iv 1dd

Remarks:

community-acquired cholangitis

Priority:
2nd choice
Medication:

amoxicilline + clavulaanzuur iv 1000/200mg 4dd

Remarks:

community-acquired cholangitis

Priority:
3rd choice
Medication:

amoxicilline + clavulaanzuur iv 1000/200mg 4dd

+

aminoglycoside iv 1dd

Remarks:

community-acquired cholangitis

Medication:

amoxicilline iv 1000mg 4dd

+

aminoglycoside iv 1dd

Remarks: nosocomiale sepsis en cholangitis
≥ 18 years

Indications: Penicillineallergie

Priority Medication Remarks
Medication:

cefuroxim iv 1500mg 3dd

+

aminoglycoside iv 1dd

Remarks:

bij niet-IgE gemedieerde penicilline-allergie

Medication:

ceftriaxon iv 2000mg 1dd

Remarks:

bij niet-IgE gemedieerde penicilline-allergie

≥ 18 years / < 20 kg
Priority Medication Remarks
Medication:

amoxicilline + clavulaanzuur iv 1000/200mg 4dd

+

aminoglycoside iv 1dd

Remarks:

nosocomiale sepsis en cholangitis

General comments

preferred regime depending on local resistance data

cholangitis: after adequate drainage of the bile ducts: treatment duration maximum 3 days

Sources

Antimicrobial resources

The following antimicrobial agents have been used in these recommendations:

External antimicrobial resources
Menu position
Metadata

Swab vid: G-436603.4
Updated: 06/25/2018 - 19:00
Status: Published